TrenMix-200 (TREA,TREE) Blend Oil Steroids Injectable 200mg/ml

Description

TrenMix Trenbolone Acetate Enanthate Blend Injectable Research

Molecular Data

• CAS Numbers: 10161-34-9 (Acetate), 10161-33-8 (Enanthate), 23454-33-3 (Hex)
• Molecular Formulas: C20H24O3, C25H34O3, C26H34O4
• Purity: >99% composite purity confirmed via HPLC-UV and GC/MS
• Appearance: Clear to pale amber viscous lipid solution
• Solubility: Optimized in organic carrier lipids like Grapeseed Oil and Ethyl Oleate

Pharmacodynamics

The pharmacology of Trenbolone Mix is defined by the trienic bond structure at carbons 9 and 11, which precludes aromatization and markedly enhances receptor affinity. Trenbolone Mix activates nuclear androgen receptors to trigger the translocation of the receptor-ligand complex into the cellular nucleus. The tri-ester matrix regulates systemic bioavailability through a staggered hydrolysis process where the acetate, hexahydrobenzylcarbonate, and enanthate chains are cleaved at different rates. Trenbolone signaling suppresses glucocorticoid receptor activity, effectively inhibiting catabolic pathways and promoting a robust positive nitrogen balance. Binding kinetics indicate an ultra-high affinity for the AR with a Ki value of approximately 1.1 nM. Quantitatively, the weighted terminal half-life of this matrix is 7.2 days ± 1.5 days. Information gain from viscosity studies indicates that the 200mg/ml solution is stabilized using a 2% Benzyl Alcohol and 20% Benzyl Benzoate ratio to prevent solute precipitation. Compared to Tren Acetate alone, TrenMix provides a multi-modal plasma curve that reduces metabolic volatility.

About This Compound

Trenbolone Mix, also known as TrenMix Oil, is a sophisticated parenteral AAS matrix engineered for sustained anabolic signaling through the strategic integration of Tren Acetate, Tren Enanthate, and Tren Hex. This tri-ester configuration facilitates immediate receptor saturation followed by a protracted release profile in advanced biological research models. Researchers prioritize this compound for investigating localized myogenic differentiation and the modulation of metabolic flux. By bypassing initial hepatic deactivation, Trenbolone Mix ensures that the composite molecules reach target tissues in their active, non-degraded configurations.

Known Effects

• Accelerated Tissue Hardening: Experimental data suggests profound increases in muscle density and visual ‘dryness’ within 10 days of administration.
• Lipolytic Pathway Stimulation: Based on community feedback, effects include significant reductions in subcutaneous fat through AR-mediated lipolysis.
• Enhanced Nutrient Partitioning: Experimental findings suggest a profound improvement in feed efficiency, allowing for lean tissue preservation during metabolic stress.
• Positive Nitrogen Flux: Observed effects include a 55-65% improvement in nitrogen retention compared to baseline controls in metabolic studies.
• IGF-1 Up-Regulation: Research models demonstrate a dose-dependent increase in localized Insulin-like Growth Factor 1 levels, supporting cellular repair.

Summary:
Trenbolone Mix remains a premier research tool for studying advanced anabolic signaling and multi-modal tissue refinement with a stable pharmacokinetic profile.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.